• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加纳 HIV 感染者中的脂蛋白(a)和高敏 C 反应蛋白:接受抗逆转录病毒治疗的 HIV 感染者心血管风险特征研究(SCRIPT)。

Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT).

机构信息

Komfo Anokye Teaching Hospital, Kumasi, GH.

Kwame Nkrumah University of Science andTechnology, School of Medicine and Dentistry, Kumasi, GH.

出版信息

Glob Heart. 2020 Nov 3;15(1):74. doi: 10.5334/gh.850.

DOI:10.5334/gh.850
PMID:33299770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7646289/
Abstract

BACKGROUND

Lipoprotein(a) [Lp(a)] and high-sensitivity C-reactive protein (hs-CRP) levels are associated with cardiovascular disease (CVD) in the general population, even after adjusting for conventional CVD risk factors. However, data are limited regarding the distribution of Lp(a) and hs-CRP among patients with HIV in Ghana. We explored levels of Lp(a), hs-CRP and other cardiovascular risk factors among people who were HIV positive (HIV+) on ART (HIV+ART+), HIV+ART-, and HIV-ART- in a Ghanaian population.

METHODS

We conducted a cross sectional study, recruited individuals who were HIV+ART+ and HIV+ART- from the largest HIV clinic in central Ghana between August 2018 and December 2019. HIV negative controls were recruited from communities and adjoining suburbs of Kumasi. Lipoprotein(a) was measured using Immunoturbidimetric assay and high sensitive-CRP concentrations were determined using particle-enhanced turbidimetric assay. We compared levels of Lp(a), hs-CRP, and conventional CVD risk factors among these groups and used multivariable stepwise logistic regression models to explore associations between them.

RESULTS

Among HIV+ART+ (n = 156), HIV+ART- (n = 131), and HIV-ART- (n = 147), mean(SD) ages were 48 (9.1) years, 41 (11.1) years and 45 (11.9) years, p = <0.001, proportion of females were 71.2%, 67.9% and 73.5% respectively. Median(IQR) concentrations of hs-CRP in mg/L were 1.7 (0.8,4.5), 2.03 (0.5,8.58) and 1.0 (0.45,2.74) across respective groups and the proportion of elevated Lp(a) concentrations (Lp[a] > 30mg/dL) were 70%, 48% and 62% among HIV+ART+,HIV+ART- and HIV-ART- participants respectively. Diabetes mellitus, dyslipidemia, waist-to-hip ratio and metabolic syndrome were associated with higher hs-CRP levels. Compared to HIV-ART-, HIV+ patients had higher odds of having hs-CRP > 3mg/L while HIV+ART+ patients had higher odds of elevated Lp(a) than HIV+ART- after multivariable adjustment.

CONCLUSION

PLWHA in Ghana are associated with higher odds of elevated hs-CRP, regardless of ART use. HIV+ART+ is significantly associated with higher odds of elevated Lp(a) levels compared to HIV+ART-; even after multivariable adjustments. Reasons for this and potential clinical implications merit further study.

摘要

背景

脂蛋白(a)[Lp(a)]和高敏 C 反应蛋白(hs-CRP)水平与普通人群中的心血管疾病(CVD)相关,即使在调整了传统 CVD 风险因素后也是如此。然而,关于加纳 HIV 患者中 Lp(a)和 hs-CRP 的分布数据有限。我们在加纳人群中研究了接受抗逆转录病毒治疗(ART)的 HIV 阳性(HIV+ART+)、未接受 ART 的 HIV 阳性(HIV+ART-)和 HIV 阴性(HIV-ART-)患者的 Lp(a)、hs-CRP 和其他心血管风险因素的水平。

方法

我们进行了一项横断面研究,从 2018 年 8 月至 2019 年 12 月期间,从加纳最大的 HIV 诊所招募了 HIV+ART+和 HIV+ART-的患者。HIV 阴性对照来自库马西的社区和邻近郊区。使用免疫比浊法测量脂蛋白(a),使用粒子增强比浊法测定高敏-CRP 浓度。我们比较了这些组之间的 Lp(a)、hs-CRP 和传统 CVD 风险因素的水平,并使用多变量逐步逻辑回归模型来探讨它们之间的关联。

结果

在 HIV+ART+(n=156)、HIV+ART-(n=131)和 HIV-ART-(n=147)中,平均(SD)年龄分别为 48(9.1)岁、41(11.1)岁和 45(11.9)岁,p<0.001,女性比例分别为 71.2%、67.9%和 73.5%。hs-CRP 的中位数(IQR)浓度(mg/L)分别为 1.7(0.8,4.5)、2.03(0.5,8.58)和 1.0(0.45,2.74),在各自的组中,Lp(a)浓度升高(Lp[a]>30mg/dL)的比例分别为 70%、48%和 62%。糖尿病、血脂异常、腰臀比和代谢综合征与 hs-CRP 水平升高相关。与 HIV-ART-相比,HIV+患者的 hs-CRP>3mg/L 的可能性更高,而 HIV+ART+患者的 Lp(a)水平升高的可能性高于 HIV+ART-,即使在多变量调整后也是如此。

结论

加纳的 PLWHA 与 hs-CRP 升高的可能性更高相关,无论是否使用 ART。与 HIV+ART-相比,HIV+ART+与 hs-CRP 升高的可能性更高显著相关;即使在多变量调整后也是如此。这种情况的原因和潜在的临床意义值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01f/7646289/c73977a0e12a/gh-15-1-850-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01f/7646289/c73977a0e12a/gh-15-1-850-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e01f/7646289/c73977a0e12a/gh-15-1-850-g1.jpg

相似文献

1
Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT).加纳 HIV 感染者中的脂蛋白(a)和高敏 C 反应蛋白:接受抗逆转录病毒治疗的 HIV 感染者心血管风险特征研究(SCRIPT)。
Glob Heart. 2020 Nov 3;15(1):74. doi: 10.5334/gh.850.
2
Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study.载脂蛋白(a)和高敏 C 反应蛋白对急性心肌梗死患者全因死亡和心血管死亡风险的协同作用:一项大型前瞻性队列研究。
Front Endocrinol (Lausanne). 2024 May 15;15:1392859. doi: 10.3389/fendo.2024.1392859. eCollection 2024.
3
A linear positive association between high-sensitivity C-reactive protein and the prevalence of cardiovascular disease among individuals with diabetes.在糖尿病患者中,高敏C反应蛋白与心血管疾病患病率之间存在线性正相关。
BMC Cardiovasc Disord. 2024 Aug 8;24(1):411. doi: 10.1186/s12872-024-04091-8.
4
LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention.LDL-C 和 hs-CRP 共同改变 Lp(a)对经皮冠状动脉介入治疗患者 5 年死亡的影响。
Clin Cardiol. 2024 Oct;47(10):e70025. doi: 10.1002/clc.70025.
5
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.脂蛋白(a)、C 反应蛋白与一级和二级预防人群的心血管风险。
JAMA Cardiol. 2024 Apr 1;9(4):385-391. doi: 10.1001/jamacardio.2023.5605.
6
Cardiovascular risk factors among Ghanaian patients with HIV: A cross-sectional study.加纳 HIV 患者的心血管危险因素:一项横断面研究。
Clin Cardiol. 2019 Dec;42(12):1195-1201. doi: 10.1002/clc.23273. Epub 2019 Sep 30.
7
Distribution of High-Sensitivity C-Reactive Protein and Its Relationship with Other Cardiovascular Risk Factors in the Middle-Aged Chinese Population.中国中年人群高敏C反应蛋白分布及其与其他心血管危险因素的关系
Int J Environ Res Public Health. 2016 Aug 31;13(9):872. doi: 10.3390/ijerph13090872.
8
High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis.高效抗逆转录病毒治疗的 HIV 感染者的高敏 C 反应蛋白:系统评价和荟萃分析。
BMC Infect Dis. 2024 Feb 2;24(1):160. doi: 10.1186/s12879-024-09050-4.
9
High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults.美国成年人的高密度脂蛋白胆固醇、高敏 C 反应蛋白与心血管疾病。
Am J Cardiol. 2012 Nov 15;110(10):1464-7. doi: 10.1016/j.amjcard.2012.06.056. Epub 2012 Aug 2.
10
Biochemical correlates of lipoprotein(a) in a general adult population. Possible implications for cardiovascular risk assessment.普通成年人群中脂蛋白(a)的生化关联。对心血管风险评估的潜在影响。
J Thromb Thrombolysis. 2009 Jan;27(1):44-7. doi: 10.1007/s11239-007-0171-0. Epub 2007 Nov 21.

引用本文的文献

1
Validity of high-sensitivity C-reactive protein versus DAD equation for cardiovascular risk assessment in people living with HIV in Nigeria.在尼日利亚的艾滋病毒感染者中,高敏C反应蛋白与DAD方程用于心血管风险评估的有效性。
BMC Infect Dis. 2025 Aug 4;25(1):978. doi: 10.1186/s12879-025-11378-4.
2
Cardiovascular Risk among People Living with HIV in Ghana.加纳艾滋病毒感染者的心血管风险
Infect Chemother. 2025 Jun;57(2):238-247. doi: 10.3947/ic.2024.0138. Epub 2025 Apr 14.
3
Serum uric acid and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy: a comparative cross-sectional study.

本文引用的文献

1
Cardiovascular risk factors among Ghanaian patients with HIV: A cross-sectional study.加纳 HIV 患者的心血管危险因素:一项横断面研究。
Clin Cardiol. 2019 Dec;42(12):1195-1201. doi: 10.1002/clc.23273. Epub 2019 Sep 30.
2
Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.脂蛋白(a):印度年轻人群中未被充分认识的恶性冠状动脉疾病遗传危险因素。
Indian Heart J. 2019 May-Jun;71(3):184-198. doi: 10.1016/j.ihj.2019.04.007. Epub 2019 May 2.
3
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.
接受多替拉韦和利托那韦增强的阿扎那韦为基础的抗逆转录病毒治疗的HIV感染者的血清尿酸和高敏C反应蛋白水平:一项比较性横断面研究
Front Med (Lausanne). 2024 Jul 17;11:1370725. doi: 10.3389/fmed.2024.1370725. eCollection 2024.
4
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection.载脂蛋白(a)与 HIV 感染者和非感染者的冠状动脉周围炎症的相关性。
J Clin Lipidol. 2024 May-Jun;18(3):e430-e443. doi: 10.1016/j.jacl.2024.02.003. Epub 2024 Feb 15.
5
High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis.高效抗逆转录病毒治疗的 HIV 感染者的高敏 C 反应蛋白:系统评价和荟萃分析。
BMC Infect Dis. 2024 Feb 2;24(1):160. doi: 10.1186/s12879-024-09050-4.
6
The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI.ART 对中国汉族 HIV 感染患者血脂谱动态变化的影响:NRTI/NNRTI 与 NRTI/INSTI 的比较。
Front Public Health. 2023 Apr 27;11:1161503. doi: 10.3389/fpubh.2023.1161503. eCollection 2023.
HIV 感染者的心血管疾病特征、预防和管理:美国心脏协会的科学声明。
Circulation. 2019 Jul 9;140(2):e98-e124. doi: 10.1161/CIR.0000000000000695. Epub 2019 Jun 3.
4
Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.加纳艾滋病毒感染者人群亚临床颈动脉粥样硬化及血管危险因素负担。
J Neurol Sci. 2019 Feb 15;397:103-111. doi: 10.1016/j.jns.2018.12.026. Epub 2018 Dec 19.
5
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年美国心脏病学会/美国心脏协会/美国心血管血管造影和介入学会/美国预防、物理治疗和康复医师学会/美国糖尿病协会/美国老年学会/美国药学会/美国医师协会/美国生理学会/北美介入放射学会/美国国家脂质协会/美国临床内分泌医师协会胆固醇管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.
6
Lipoprotein(a).脂蛋白(a)
Eur Heart J. 2017 May 21;38(20):1530-1532. doi: 10.1093/eurheartj/ehx233.
7
The Burden of Cardiovascular Diseases Among US States, 1990-2016.美国各州 1990-2016 年心血管疾病负担
JAMA Cardiol. 2018 May 1;3(5):375-389. doi: 10.1001/jamacardio.2018.0385.
8
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.NHLBI 工作组降低脂蛋白(a)介导的心血管疾病和主动脉狭窄风险的建议。
J Am Coll Cardiol. 2018 Jan 16;71(2):177-192. doi: 10.1016/j.jacc.2017.11.014.
9
Current trends in admissions and outcomes of cardiac diseases in Ghana.加纳心脏病的入院情况及治疗结果的当前趋势。
Clin Cardiol. 2017 Oct;40(10):783-788. doi: 10.1002/clc.22753. Epub 2017 Jul 10.
10
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016年美国心脏协会/美国心脏病学会下肢外周动脉疾病患者管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2017 Mar 21;69(11):1465-1508. doi: 10.1016/j.jacc.2016.11.008. Epub 2016 Nov 13.